Endometriosis impacts 1 in 10 Canadians, yet the financial burden it creates is not well understood. Although universal healthcare covers physician and hospital services, patients incur significant out-of-pocket costs for medications, complementary therapies, fertility treatments, travel, and childcare. These expenses can delay care and treatment, leading to increased health disparities. Existing international evidence highlights the extent of financial strain related to endometriosis, but Canada currently lacks sufficient patient-level data to inform effective interventions. This commentary emphasizes the need for a thorough quantitative assessment of the financial impact on patients and advocates for policy reforms. Proposed changes include implementing pharmacare, providing universal coverage for fertility treatments, and improving access to complementary therapies. These measures aim to ensure that Canadians with endometriosis receive timely and comprehensive care.